{
  "created_at": "Fri Feb 18 6:25:33 +0000 2022",
  "id_str": "1494547886335569921",
  "full_text": "The firm plans to send its containerised mRNA factories—which it calls Biontainers—to parts of the world which lack their own vaccine-manufacturing capabilities https://t.co/IeaXGz0e3K",
  "display_text_range": [
    0,
    184
  ],
  "entities": {
    "hashtags": [],
    "symbols": [],
    "user_mentions": [],
    "urls": [
      {
        "url": "https://t.co/IeaXGz0e3K",
        "expanded_url": "https://econ.st/3rZqupO",
        "display_url": "econ.st/3rZqupO",
        "indices": [
          161,
          184
        ]
      }
    ]
  },
  "user": {
    "name": "The Economist",
    "screen_name": "TheEconomist",
    "profile_image_url_https": "https://pbs.twimg.com/profile_images/879361767914262528/HdRauDM-_normal.jpg"
  },
  "retweet_count": 39,
  "favorite_count": 100,
  "possibly_sensitive": false,
  "original_created_at": "Fri Feb 18 05:42:38 +0000 2022"
}